Syra Health Corp. Announces Director Changes and Officer Compensation
Ticker: SYRA · Form: 8-K · Filed: May 1, 2025 · CIK: 1922335
| Field | Detail |
|---|---|
| Company | Syra Health Corp (SYRA) |
| Form Type | 8-K |
| Filed Date | May 1, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: governance, officer-compensation, director-change
TL;DR
Syra Health board shakeup: Dr. Johnson out, Dr. Smith in. Officer pay details also filed.
AI Summary
Syra Health Corp. announced on April 25, 2025, the departure of director Dr. David L. Johnson and the appointment of new director Dr. Michael J. Smith. The company also reported on compensatory arrangements for its officers.
Why It Matters
Changes in board composition and executive compensation can signal shifts in company strategy or governance, impacting investor confidence.
Risk Assessment
Risk Level: low — This filing primarily concerns routine corporate governance changes and compensation disclosures, with no immediate financial distress indicated.
Key Players & Entities
- Syra Health Corp. (company) — Registrant
- Dr. David L. Johnson (person) — Departing Director
- Dr. Michael J. Smith (person) — Appointed Director
- April 25, 2025 (date) — Date of earliest event reported
FAQ
Who is the new director appointed to Syra Health Corp.'s board?
Dr. Michael J. Smith was appointed as a new director.
Who has departed from Syra Health Corp.'s board of directors?
Dr. David L. Johnson has departed from the board of directors.
What is the exact date of the earliest event reported in this 8-K filing?
The earliest event reported is dated April 25, 2025.
What specific items are covered in this Form 8-K filing?
The filing covers the departure of directors, election of directors, appointment of officers, and compensatory arrangements of certain officers.
In which state is Syra Health Corp. incorporated?
Syra Health Corp. is incorporated in Delaware.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 1, 2025 by Dr. David L. Johnson regarding Syra Health Corp (SYRA).